Digital twins help improve the treatment of Acute Respiratory Distress Syndrome (ARDS)
Following many years of research at the Technical University of Munich, the start-up Ebenbuild GmbH aims to fundamentally improve the mechanical ventilation of ICU patients with ARDS and drive significant, long-term improvements in treatment outcomes. The company develops personalized simulation models of patients’ lungs using patient data, such as medical images. These Digital Twins allow doctors to make sound treatment decisions by accurately picturing how mechanical ventilation will affect individual patients. The company was founded in April 2019 by Dr. Kei Müller, Dr. Jonas Biehler, Prof. Wolfgang Wall, and Dr. Karl-Robert Wichmann. Now the team secured seven-figure funding as part of a seed financing round.